Diagnosis and management of invasive fungal infections due to non-Aspergillus moulds
- PMID: 40085540
- PMCID: PMC11908538
- DOI: 10.1093/jac/dkaf005
Diagnosis and management of invasive fungal infections due to non-Aspergillus moulds
Abstract
Invasive fungal infection (IFI) due to moulds other than Aspergillus are a significant cause of morbidity and mortality. Non-Aspergillus mould (NAM) infections appear to be on the increase due to an ever-expanding population of immunocompromised hosts. In this review, Mucorales, Scedosporium species, Lomentospora prolificans and Fusarium species are examined in detail, and the microbiology, risk factors, diagnosis and treatment of emerging NAMs such as Paecilomyces variotti, Purpureocillium lilacinum and Rasamsonia are summarized. The challenges in diagnosis are emphasized and the emerging importance of molecular methods is discussed. Treatment of IFI due to NAMs is a multi-pronged and multi-disciplinary approach. Surgery, correction of underlying risk factors, and augmentation of the host immune response are as important as antifungal therapy. Many of these NAMs are intrinsically resistant to the currently licensed antifungal agents, so selection of therapy needs to be guided by susceptibility testing. There are new antifungal agents in development, and these have the potential to improve the efficacy and safety of antifungal treatment in the future. Ongoing research is required to fully delineate the epidemiology of NAM infections, and to develop better diagnostic tools and treatments so that outcomes from these infections can continue to improve.
© The Author(s) 2025. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
Figures







Similar articles
-
Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021.Intern Med J. 2021 Nov;51 Suppl 7:177-219. doi: 10.1111/imj.15592. Intern Med J. 2021. PMID: 34937139
-
Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses.Semin Respir Crit Care Med. 2020 Feb;41(1):115-130. doi: 10.1055/s-0039-3401989. Epub 2020 Jan 30. Semin Respir Crit Care Med. 2020. PMID: 32000288 Review.
-
Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy.Int J Antimicrob Agents. 2018 Nov;52(5):706-712. doi: 10.1016/j.ijantimicag.2018.08.005. Epub 2018 Aug 9. Int J Antimicrob Agents. 2018. PMID: 30099056 Free PMC article.
-
Changes in the epidemiological landscape of invasive mould infections and disease.J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i5-i11. doi: 10.1093/jac/dkx028. J Antimicrob Chemother. 2017. PMID: 28355462
-
Emerging moulds: epidemiological trends and antifungal resistance.Mycoses. 2011 Nov;54(6):e666-78. doi: 10.1111/j.1439-0507.2011.02032.x. Epub 2011 Jun 14. Mycoses. 2011. PMID: 21672045 Review.
References
-
- Kontoyiannis DP, Marr KA, Park BJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant-associated infection surveillance network (TRANSNET) database. Clin Infect Dis 2010; 50: 1091–100. 10.1086/651263 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical